S&P 500   4,577.96 (+1.44%)
DOW   34,643.74 (+1.83%)
QQQ   388.88 (+0.45%)
AAPL   162.84 (-1.17%)
MSFT   330.37 (+0.09%)
FB   308.36 (-0.72%)
GOOGL   2,856.21 (+1.25%)
AMZN   3,440.22 (-0.10%)
TSLA   1,074.72 (-1.85%)
NVDA   320.08 (+1.82%)
BABA   120.95 (-1.26%)
NIO   35.34 (-7.75%)
CGC   9.95 (+0.10%)
AMD   149.45 (+0.23%)
GE   94.85 (+1.99%)
MU   82.84 (-2.71%)
T   23.06 (+3.73%)
F   19.80 (+1.12%)
DIS   145.98 (+2.69%)
PFE   53.38 (-2.38%)
AMC   29.53 (+3.36%)
ACB   5.94 (-1.16%)
BA   197.71 (+5.06%)
S&P 500   4,577.96 (+1.44%)
DOW   34,643.74 (+1.83%)
QQQ   388.88 (+0.45%)
AAPL   162.84 (-1.17%)
MSFT   330.37 (+0.09%)
FB   308.36 (-0.72%)
GOOGL   2,856.21 (+1.25%)
AMZN   3,440.22 (-0.10%)
TSLA   1,074.72 (-1.85%)
NVDA   320.08 (+1.82%)
BABA   120.95 (-1.26%)
NIO   35.34 (-7.75%)
CGC   9.95 (+0.10%)
AMD   149.45 (+0.23%)
GE   94.85 (+1.99%)
MU   82.84 (-2.71%)
T   23.06 (+3.73%)
F   19.80 (+1.12%)
DIS   145.98 (+2.69%)
PFE   53.38 (-2.38%)
AMC   29.53 (+3.36%)
ACB   5.94 (-1.16%)
BA   197.71 (+5.06%)
S&P 500   4,577.96 (+1.44%)
DOW   34,643.74 (+1.83%)
QQQ   388.88 (+0.45%)
AAPL   162.84 (-1.17%)
MSFT   330.37 (+0.09%)
FB   308.36 (-0.72%)
GOOGL   2,856.21 (+1.25%)
AMZN   3,440.22 (-0.10%)
TSLA   1,074.72 (-1.85%)
NVDA   320.08 (+1.82%)
BABA   120.95 (-1.26%)
NIO   35.34 (-7.75%)
CGC   9.95 (+0.10%)
AMD   149.45 (+0.23%)
GE   94.85 (+1.99%)
MU   82.84 (-2.71%)
T   23.06 (+3.73%)
F   19.80 (+1.12%)
DIS   145.98 (+2.69%)
PFE   53.38 (-2.38%)
AMC   29.53 (+3.36%)
ACB   5.94 (-1.16%)
BA   197.71 (+5.06%)
S&P 500   4,577.96 (+1.44%)
DOW   34,643.74 (+1.83%)
QQQ   388.88 (+0.45%)
AAPL   162.84 (-1.17%)
MSFT   330.37 (+0.09%)
FB   308.36 (-0.72%)
GOOGL   2,856.21 (+1.25%)
AMZN   3,440.22 (-0.10%)
TSLA   1,074.72 (-1.85%)
NVDA   320.08 (+1.82%)
BABA   120.95 (-1.26%)
NIO   35.34 (-7.75%)
CGC   9.95 (+0.10%)
AMD   149.45 (+0.23%)
GE   94.85 (+1.99%)
MU   82.84 (-2.71%)
T   23.06 (+3.73%)
F   19.80 (+1.12%)
DIS   145.98 (+2.69%)
PFE   53.38 (-2.38%)
AMC   29.53 (+3.36%)
ACB   5.94 (-1.16%)
BA   197.71 (+5.06%)
NASDAQ:MTBC

CareCloud Stock Forecast, Price & News

$6.56
-0.04 (-0.61%)
(As of 12/2/2021 11:01 AM ET)
Add
Compare
Today's Range
$6.51
$6.61
50-Day Range
$6.60
$8.36
52-Week Range
$6.60
$12.84
Volume
272 shs
Average Volume
111,994 shs
Market Capitalization
$97.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.83
30 days | 90 days | 365 days | Advanced Chart
Receive MTBC News and Ratings via Email

Sign-up to receive the latest news and ratings for CareCloud and its competitors with MarketBeat's FREE daily newsletter.


CareCloud logo

About CareCloud

CareCloud, Inc. brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows, and make better business and care decisions. More than 40,000 providers across the United States count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Services and solutions include revenue cycle management (RCM), practice management (PM), electronic health record (EHR), business intelligence, telehealth, and patient experience management (PXM). CareCloud is headquartered in Somerset, NJ.

Headlines

CareCloud, Inc. (NASDAQ:MTBC) Director Sells $35,000.00 in Stock
December 1, 2021 |  americanbankingnews.com
-$0.17 EPS Expected for CareCloud, Inc. (NASDAQ:MTBC) This Quarter
November 18, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:MTBC
Employees
3,700
Year Founded
N/A

Sales & Book Value

Annual Sales
$105.12 million
Cash Flow
$0.30 per share
Book Value
$7.68 per share

Profitability

Net Income
$-8.81 million
Pretax Margin
-0.35%

Debt

Price-To-Earnings

Miscellaneous

Free Float
9,356,000
Market Cap
$97.58 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/04/2021
Today
12/02/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/24/2022

MarketRank

Overall MarketRank

2.36 out of 5 stars

Medical Sector

231st out of 1,392 stocks

Prepackaged Software Industry

57th out of 266 stocks

Analyst Opinion: 3.5Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -












CareCloud (NASDAQ:MTBC) Frequently Asked Questions

Is CareCloud a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CareCloud in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CareCloud stock.
View analyst ratings for CareCloud
or view top-rated stocks.

How has CareCloud's stock been impacted by COVID-19?

CareCloud's stock was trading at $5.31 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MTBC shares have increased by 23.5% and is now trading at $6.56.
View which stocks have been most impacted by COVID-19
.

Are investors shorting CareCloud?

CareCloud saw a decline in short interest in the month of November. As of November 15th, there was short interest totaling 209,400 shares, a decline of 25.1% from the October 31st total of 279,400 shares. Based on an average daily trading volume, of 68,500 shares, the short-interest ratio is presently 3.1 days. Currently, 2.3% of the company's shares are sold short.
View CareCloud's Short Interest
.

When is CareCloud's next earnings date?

CareCloud is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for CareCloud
.

How were CareCloud's earnings last quarter?

CareCloud, Inc. (NASDAQ:MTBC) issued its earnings results on Thursday, November, 4th. The technology company reported ($0.15) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.19) by $0.04. CareCloud had a negative net margin of 0.40% and a negative trailing twelve-month return on equity of 0.53%. During the same quarter in the previous year, the company posted ($0.46) EPS.
View CareCloud's earnings history
.

What price target have analysts set for MTBC?

3 brokerages have issued 1 year price objectives for CareCloud's stock. Their forecasts range from $15.00 to $20.00. On average, they expect CareCloud's stock price to reach $18.33 in the next year. This suggests a possible upside of 179.5% from the stock's current price.
View analysts' price targets for CareCloud
or view top-rated stocks among Wall Street analysts.

What is Mahmud Haq's approval rating as CareCloud's CEO?

71 employees have rated CareCloud CEO Mahmud Haq on Glassdoor.com. Mahmud Haq has an approval rating of 47% among CareCloud's employees. This puts Mahmud Haq in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of CareCloud own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CareCloud investors own include NVIDIA (NVDA), Inseego (INSG), JD.com (JD), Marvell Technology (MRVL), Niu Technologies (NIU), Bilibili (BILI), Alibaba Group (BABA), Baidu (BIDU), BioXcel Therapeutics (BTAI) and Baozun (BZUN).

What is CareCloud's stock symbol?

CareCloud trades on the NASDAQ under the ticker symbol "MTBC."

Who are CareCloud's major shareholders?

CareCloud's stock is owned by a variety of retail and institutional investors. Top institutional investors include P.A.W. Capital Corp (4.69%), Franklin Resources Inc. (2.63%), Apollo Management Holdings L.P. (1.41%), Advisor Group Holdings Inc. (0.88%), Dimensional Fund Advisors LP (0.75%) and Gabelli Funds LLC (0.71%). Company insiders that own CareCloud stock include A Hadi Chaudhry, Anne Busquet, Bill Korn, Cameron Munter, John N Daly, Kimberly J Blanche, Kimberly J Grant, Mahmud Ul Haq, Shruti H Patel and Stephen Andrew Snyder.
View institutional ownership trends for CareCloud
.

Which major investors are selling CareCloud stock?

MTBC stock was sold by a variety of institutional investors in the last quarter, including Apollo Management Holdings L.P., Squarepoint Ops LLC, Citadel Advisors LLC, UBS Group AG, and BlackRock Inc.. Company insiders that have sold CareCloud company stock in the last year include A Hadi Chaudhry, Anne Busquet, Bill Korn, John N Daly, Mahmud Ul Haq, and Stephen Andrew Snyder.
View insider buying and selling activity for CareCloud
or view top insider-selling stocks.

Which major investors are buying CareCloud stock?

MTBC stock was bought by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Gabelli Funds LLC, Franklin Resources Inc., P.A.W. Capital Corp, Advisor Group Holdings Inc., Morgan Stanley, and Marshall Wace LLP.
View insider buying and selling activity for CareCloud
or or view top insider-buying stocks.

How do I buy shares of CareCloud?

Shares of MTBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CareCloud's stock price today?

One share of MTBC stock can currently be purchased for approximately $6.56.

How much money does CareCloud make?

CareCloud has a market capitalization of $97.58 million and generates $105.12 million in revenue each year. The technology company earns $-8.81 million in net income (profit) each year or ($0.77) on an earnings per share basis.

How many employees does CareCloud have?

CareCloud employs 3,700 workers across the globe.

What is CareCloud's official website?

The official website for CareCloud is www.carecloud.com.

Where are CareCloud's headquarters?

CareCloud is headquartered at 7 CLYDE ROAD, SOMERSET NJ, 08873.

How can I contact CareCloud?

CareCloud's mailing address is 7 CLYDE ROAD, SOMERSET NJ, 08873. The technology company can be reached via phone at 732-873-5133 or via fax at 732-873-3378.


This page was last updated on 12/2/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.